(SLE)
VULINACIMAB(INNC)
IMMUNOGLOBULIN G1-KAPPA, ANTI-[HOMO SAPIENS VEGFR2 (VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2, KDR, KINASE INSERT DOMAIN RECEPTOR, FLK1, CD309)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-447) [VH (HOMO SAPIENS IGHV3-23*04 (90.8%) -(IGHD) - IGHJ1*01 (100%)) [8.8.10] (1-117) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R120>K (214) (118-215), HINGE 1-15 (216-230), CH2 (231-340), CH3 E12 (356), M14 (358) (341-445), CHS (446-457)) (118-447)], (220-219')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-219') [V-KAPPA (HOMO SAPIENS IGKV2-30*01 (83.0%) -IGKJ2*01 (100%)) [11.3.9] (1'- 112') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1 (158), V101 (196) (113'-219')]; DIMER (226-226":229-229")-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA(WHO)
VULINACIMABUM(INN)